CancerNetwork Members: Login | Register
CancerNetwork SearchMedica Medline Drugs

Powered by SearchMedica

 
PUBLICATIONS
NEWS
PODCASTS
TOPICS
BLOGS
NURSES
PATIENTS
JOBS
CONFERENCES
CME
SUPPLEMENTS
 

Home » CONFERENCES » AACR 2012

CONFERENCE REPORT 

Photoacoustic Tomography: Ultrasonically Breaking Through the Optical Diffusion Limit

2012 Annual Meeting of the American Association for Cancer Research

By Michael Kaufman | April 5, 2012

A wealth of data presented in posters, symposia, panel discussions, and plenary sessions at the 2012 meeting of the American Association for Cancer Research truly reflected this year’s theme, “Accelerating Science: Concept to Clinic.” The following is the first of a series of summaries of some of these presentations.

Photoacoustic tomography (PAT), a new imaging technique that relies on light and sound, provides in vivo multiscale nonionizing functional and molecular imaging without the radiation emitted by x-rays and CT scans, explained Lihong V. Wang, PhD, who led the team of developers at Washington University in St. Louis.

Lihong V. Wang, PhD
(MORE: 'Striking' Results Seen in Phase II Trial of Selumetinib in Women With Recurrent Low-Grade Serous Carcinoma of the Ovary or Peritoneum)

“PAT is the only modality capable of imaging across the length scales of organelles, cells, tissues, and organs with consistent contrast,” said Dr. Wang. The technique “has the potential to empower multiscale systems biology and accelerate translation from microscopic laboratory discoveries to macroscopic clinical practice.”

Dr. Wang said PAT may also hold the key to the earliest detection of cancer by in vivo label-free quantification of hypermetabolism, which he called “the quintessential hallmark of cancer.”

Dr. Wang is working with physicians at Washington University to evaluate PAT for use in identifying the sentinel lymph nodes for breast cancer staging (which may eliminate the need for surgical lymph node biopsies); monitoring early response to chemotherapy; imaging melanomas; and imaging the gastrointestinal tract.

“This technology is potentially a game changer, both in how we monitor cancer and in how soon we know it is there,” said Dr. Wang.

 

Join the Conversation

Want to join the conversation? If you're a healthcare professional, we'd like to hear your comments. Just sign in or register today to become part of our growing, online community.

Presentations Reflect Theme of 2012 AACR Meeting, ‘Accelerating Science: Concept to Clinic’

Photoacoustic Tomography: Ultrasonically Breaking Through the Optical Diffusion Limit

Development of a Novel Therapeutic Agent for Breast Cancer Based on a New Pathway Analysis of Triple-Negative Breast Cancer

Hypofractionated Stereotactic Radiotherapy to Surgical Cavity After Resection for Brain Metastasis

Cytokine Signaling Through JAK2/STAT3 Pathway is a Viable Therapeutic Target in NSCLC

'Striking' Results Seen in Phase II Trial of Selumetinib in Women With Recurrent Low-Grade Serous Carcinoma of the Ovary or Peritoneum






 
AACR 2012 COVERAGE

Inotuzumab Ozogamicin Achieves ‘Markedly Long’ Antitumor Response in Indolent B-Cell NHL
April 5, 2012
NIH Research Funding Faces ‘Unprecedented Threat’
April 5, 2012
Hypofractionated Stereotactic Radiotherapy to Surgical Cavity After Resection for Brain Metastasis
April 5, 2012
Development of a Novel Therapeutic Agent for Breast Cancer Based on a New Pathway Analysis of Triple-Negative Breast Cancer
April 5, 2012
'Striking' Results Seen in Phase II Trial of Selumetinib in Women With Recurrent Low-Grade Serous Carcinoma of the Ovary or Peritoneum
April 5, 2012
 
TOPIC INDEX

Cancer Types

 
  • Breast
  • Breast (HER2+)
  • Breast (Triple-Negative)
  • CML
  • Colorectal
  • Gastrointestinal
  • GIST
  • Genitourinary
  • Gynecologic
  • Head & Neck
  • Hematology
  • Kidney (Renal Cell)
  • Leukemia
  • Lung
  • Lymphoma
  • Melanoma
  • Multiple Myeloma
  • Ovarian
  • Prostate
  • Sarcoma

Supportive Care

More Topics

  • Bone Metastases
  • End-of-Life Care
  • Palliative Care
  • Ethics in Oncology
  • Practice Management
  • Practice & Policy


All Topics 


 
MOST POPULAR
  • Most Popular
  • Most Emailed
  • Most Recent
  • Dermatologic Adverse Events Associated With Targeted Therapies
  • Colorectal Lesions
  • “This Is My Last Day on Earth”
  • Slide Show: Squamous Cell Carcinoma of the Head and Neck
  • The ABCDEs of Moles and Melanomas
  • “This Is My Last Day on Earth”
  • Dermatologic Adverse Events Associated With Targeted Therapies
  • Recurrent Epithelial Ovarian Cancer: An Update on Treatment
  • Colorectal Lesions
  • ONS: Understanding Spirituality and How It Can Be Used to Help Patients
  • Bone Metastases
  • Palliative Radiotherapy in Elderly Patients With Bone Metastases Improves Quality of Life
  • Staying Fit Could Ward Off Lung and Colorectal Cancer for Middle-Age Men
  • Obesity Impairs Efficacy of L-Asparaginase in Leukemia Treatment
  • New AUA Guidelines for Prostate Cancer Screening
Click here to subscribe to our newsletter



CancerNetwork | ConsultantLive | Diagnostic Imaging | Musculoskeletal Network | OBGYN.net | PediatricsConsultantLive |
Physicians Practice | Psychiatric Times | SearchMedica | Medical Resources

© 1996 - 2013 UBM Medica LLC, a UBM company
Privacy Statement - Terms of Service - Advertising Information - Editorial Policy Statement - UBM Medica Network Privacy Policy